Published on 6/23/2004 in the Prospect News Convertibles Daily.
New Issue: ABN Amro sells $1.85 million 9% reverse exchangeables linked to Genentech
New York, June 23 - ABN Amro Bank NV priced $1.85 million of one-year 9% reverse exchangeable notes linked to Genentech Inc. stock, according to a 424B3 filing with the Securities and Exchange Commission.
| Issuer: | ABN Amro Bank NV
|
| Issue: | Reverse exchangeable senior medium-term notes
|
| Underlying stock: | Genentech Inc.
|
| Amount: | $1.85 million
|
| Maturity: | June 23, 2005
|
| Coupon: | 9%
|
| Price: | Par
|
| Payout at maturity: | Smaller of par in cash or 18.315 shares of Genentech stock
|
| Exchange ratio: | 18.315
|
| Exchange price: | $54.60 (initial level of Genentech stock)
|
| Call: | Non-callable
|
| Pricing date: | June 18
|
| Settlement date: | June 23
|
| Lead manager: | ABN Amro Financial Services
|
| Distribution: | Off shelf
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
